tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Cash flow

Compare
1,677 Followers

Allogene Therapeutics Cash Flow

ALLO's free cash flow for Q4 2025 was $-27.60M. For the 2025 fiscal year, ALLO's free cash flow was decreased by $51.36M and operating cash flow was $-27.60M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -149.25M$ -200.30M$ -237.73M$ -220.52M$ -184.81M
Investing Cash Flow
$ 95.56M$ 75.69M$ 163.29M$ 106.16M$ 163.66M
Financing Cash Flow
$ 30.16M$ 116.67M$ 95.69M$ 2.95M$ 11.96M
End Cash Position
$ 61.98M$ 85.51M$ 93.45M$ 72.20M$ 183.61M
Free Cash Flow
$ -149.63M$ -200.99M$ -239.25M$ -225.71M$ -206.26M
Currency in USD

Allogene Therapeutics Cash Flow